Mexico updates law on genomic research
This article was originally published in Scrip
Mexico has taken measures for the first time to prevent abuses involving genomic research and the inappropriate use of genomic information. A decree amending the country's general health law to this effect was published in the official state diary last month.
You may also be interested in...
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
Patient access schemes have helped the Scottish Medicines Consortium recommend rare disease products, including Regeneron/Sanofi’s Libtayo for skin cancer.